Mepolizumab and OCS Use in Eosinophilic Granulomatosis With Polyangiitis
A post-hoc analysis of the MIRRA trial of mepolizumab assessed the corticosteroid-sparing effect of mepolizumab in patients with EGPA.
A post-hoc analysis of the MIRRA trial of mepolizumab assessed the corticosteroid-sparing effect of mepolizumab in patients with EGPA.
Is omalizumab equally efficacious in treating allergic asthma among children from varying racial/ethnic backgrounds?
How effective are house dust mite sublingual immunotherapy tablets in controlling allergic rhinitis/conjunctivitis in adults and adolescents?
A recent study demonstrates an approach for evaluating and managing patients with adverse events following immunization with the COVID-19 vaccine.
Research presented at ACAAI 2021 assessed associations between IBD, eosinophilic esophagitis, esophageal eosinophilia, and atopic disease in children.
How does oral immunotherapy succeed in stopping individuals with peanut allergies from experiencing an allergic reaction to peanuts?
CHRONICLE investigators reported results of a patient survey on common asthma triggers at ACAAI 2021.
The SINUS-24/52 trial evaluated dupilumab’s impact on CRSwNP and comorbid asthma, looking at baseline asthma characteristics.
In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma.
Asthma control as measured by AIRQ may predict 12-month HRQoL, according to research reported at the 2021 ACAAI Annual Scientific Meeting.